Fauci Set to Face Senate Questioning Wednesday on Gain-of-Function Research, Prior Testimony, and Pandemic Origins

Former National Institute of Allergy and Infectious Diseases Director Anthony Fauci is scheduled to appear Wednesday morning before the Senate Homeland Security and Governmental Affairs Committee under subpoena, where he is expected to face pointed questioning from Chairman Rand Paul and other members over the federal government’s funding of potentially risky coronavirus research, his earlier statements to Congress, and related issues surrounding the origins of COVID-19.

The hearing is set for 8:30 a.m. in the Dirksen Senate Office Building. Paul, a longtime critic of Fauci’s leadership during the pandemic, issued the subpoena last month after Fauci declined to appear voluntarily following earlier negotiations. Paul has made clear that the session will revisit Fauci’s May 2021 testimony in which he stated that the National Institutes of Health had not funded gain-of-function research at the Wuhan Institute of Virology. Subsequent disclosures, including acknowledgment by then-Acting NIH Director Lawrence Tabak that certain experiments met a broader definition of such research, have kept the issue alive.

Lawmakers are expected to press Fauci on NIH grants routed through EcoHealth Alliance that supported experiments involving bat coronaviruses modified in ways that enhanced their ability to infect human cells. Paul has repeatedly argued that these projects constituted gain-of-function work and that Fauci’s denials misled Congress. The Kentucky Republican has also indicated he will examine questions around the destruction or deletion of records, Fauci’s private versus public assessments of a possible lab origin for the virus, and the circumstances of the broad preemptive pardon issued by former President Joe Biden covering potential federal offenses related to Fauci’s official duties from 2014 to 2025.

Because of that pardon, Fauci cannot invoke the Fifth Amendment against self-incrimination on federal matters covered by it, a point Paul has highlighted as ensuring fuller answers. Paul has described the pardon as unusually vague and has suggested its validity could face legal challenges, though no such challenge has yet altered the hearing plans. Additional topics may include Fauci’s influence on scientific publications and intelligence assessments regarding the pandemic’s origins, areas that have drawn renewed attention following the recent declassification of related documents.

Fauci, now 85, has consistently maintained that the NIH did not fund gain-of-function research as defined by the stricter regulatory criteria in place at the time and that available evidence points to a natural origin for SARS-CoV-2 rather than a laboratory incident. He has previously rejected accusations of misleading Congress and defended the scientific oversight of the grants in question. Wednesday’s appearance will mark one of the most high-profile congressional examinations of his record since the height of the pandemic, occurring under a Republican-led committee that has spent months reviewing millions of pages of documents related to the government’s COVID-19 response.

The session is likely to be contentious, given the history of sharp exchanges between Paul and Fauci in earlier hearings. Committee members on both sides will have opportunities to question the former official, but the agenda has been shaped primarily by Paul’s stated priorities: accountability for research funding decisions, the accuracy of past testimony under oath, and the broader handling of information about the virus’s emergence. The outcome of the hearing will not itself determine any legal consequences, yet it is positioned to create a detailed public record on issues that continue to divide lawmakers and the public more than six years after the pandemic began.